D
Bausch + Lomb Corporation BLCO.TO
TSX
Recommendation
Prev Close
$23.28
Volume
--
Avg Vol (90D)
1,951
Market Cap
$6.01B
Dividend & Yield
--
52-Week Range
$14.56 - $27.12
P/E (TTM)
--
EPS (TTM)
-$0.87
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Bausch + Lomb Announces Two Board of Directors Appointments
12/17/2025 - GuruFocus
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
12/17/2025 - Nasdaq News: Markets
Bausch + Lomb Announces Two Board of Directors Appointments
12/17/2025 - Business Wire
Fund Exits $6.6 Million Bausch + Lomb Stake as Shares Lag by 9% This Past Year
12/17/2025 - Fool.com Headlines
Large-Scale Debt Refinancing And Pipeline Optimism Might Change The Case For Investing In Bausch + Lomb (BLCO)
12/17/2025 - Simply Wall St
Critical Review: Bausch + Lomb (NYSE:BLCO) vs. Amplifon (OTCMKTS:AMFPF)
12/16/2025 - Ticker Report
Bausch + Lomb: I Need To See Stability Before Upgrading This Name
12/15/2025 - SeekingAlpha
Nomura Holdings Inc. Cuts Holdings in Bausch + Lomb Corporation $BLCO
12/15/2025 - MarketBeat
Bausch + Lomb (NYSE:BLCO) valuation after analyst upgrades highlight confidence in growth and margin improvement
12/15/2025 - Simply Wall St
Bausch + Lomb (BLCO) Refinances Loans with New $2.8 Billion Term B Allocation
12/12/2025 - GuruFocus
Bausch + Lomb Announces $2.8 Billion Loan Refinancing
12/12/2025 - TipRanks Financial Blog
Bausch + Lomb allocates $2.8 bln in new term loans to refinance existing debt
12/12/2025 - Seeking Alpha - Healthcare
Bausch + Lomb allocates $2.8 bln in new term loans to refinance existing debt
12/12/2025 - SeekingAlpha.com: All News
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
12/12/2025 - GuruFocus
Bausch + Lomb Announces Refinancing of Outstanding Term B Loans
12/12/2025 - Business Wire
Bausch + Lomb (BLCO) and Penumbra (PEN) Upgraded by Citi Amid Positive MedTech Outlook
12/11/2025 - GuruFocus
Why Bausch + Lomb (BLCO) Stock Is Trading Up Today
12/11/2025 - StockStory Articles
Bausch + Lomb upgraded to Buy from Neutral at Citi
12/11/2025 - TipRanks Financial Blog
Bausch + Lomb just upgraded at Citi, here's why
12/11/2025 - The Fly
Alembic gets USFDA nod for generic eye infection treatment suspension
12/11/2025 - Business Standard - Companies & Industry
3 Healthcare Stocks We Think Twice About
12/11/2025 - StockStory Articles
Bausch + Lomb Corporation $BLCO Stock Holdings Raised by Goldentree Asset Management LP
12/9/2025 - MarketBeat
Arrowstreet Capital Limited Partnership Decreases Stock Holdings in Bausch + Lomb Corporation $BLCO
12/9/2025 - MarketBeat
Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking Globus Medical (NYSE:GMED)
12/9/2025 - StockStory Articles
Oaktree Capital Management LP Makes New Investment in Bausch + Lomb Corporation $BLCO
12/5/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$4.98B
EBITDA (TTM)
$544.00M
EBIT (TTM)
$116.00M
Net Income (TTM)
-$305.00M
Balance Sheet
Total Assets (Q)
$13.83B
Total Debt (Q)
$4.95B
Total Liabilities (Q)
$7.33B
Book Value Per Share (Q)
$18.16
Cash Flow
Cash from Operations (TTM)
$169.00M
Cash from Investing (TTM)
-$452.00M
Cash from Financing (TTM)
$255.00M
Net Change in Cash (TTM)
-$18.00M
Filings
Filing Date
Wednesday, October 29, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
1.03
7-Day Total Return
-4.23%
30-Day Total Return
-1.61%
60-Day Total Return
4.72%
90-Day Total Return
17.16%
Year to Date Total Return
-15.30%
1-Year Total Return
-18.53%
2-Year Total Return
9.08%
3-Year Total Return
8.81%
5-Year Total Return
--
52-week Low
Apr 30, 2025 - $14.56
52-week High
Dec 18, 2024 - $27.12
Valuation
Market Cap
$6.01B - Mid Cap
Enterprise Value
$10.73B
Price/Sales (TTM)
1.66
Price/Book (Q)
1.28
Dividends and Shares
Shares Outstanding
354.20
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.bausch.com
Phone Number
905-695-7700
Address
520 Applewood Crescent
Vaughan, ON L4K 4B4
Country
Canada
Year Founded
1853
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and... more